poi_thought_leadership_header_8

We asked global Investigators - what's the outlook for Biosimilars?

188 global investigators evaluate efficacy, coverage and opportunity for biologics and biosimilars in clinical development. Learn more in our infographic.

Take A Look >

Feasibility in Clinical Research: Tips for Preparing a Successful Trial

At Pharm-Olam, we believe that a high-quality feasibility assessment sets up your development program for future success. Learn more in our infographic.

Take A Look >

Tips for Orphan Drug Development

Favorable conditions have put a spotlight on orphan drug clinical trials. We lay out tips to successfully conduct these trials and bring products to market.

Take A Look >

13 Reasons to Choose Belgium for Your Next Trial

Our research shows that Belgium is the #1 location in Europe for research activity. To learn more about its benefits of this region, view our infographic.

Take A Look >

13 Tips to Overcome Design & Operational Challenges in Biosimilar Clinical Development

Based on the experience of our internal team, we have created a series of 13 study design and operational tips for your use. View them in our graphic.

Take A Look >

Reconsidering India as a Clinical Trial Location

Revised regulations in India warrant a fresh look into the region, as it could now be a viable country to run clinical trials. See why in our whitepaper.

Take A Look >

Canada: A Separate but Familiar Place for Clinical Research

Canada boasts a large population and favorable research conditions. See our infographic to learn what Canada has to offer as a site for clinical research.

Take A Look >

Can the Horizon 2020 programme help fund your next study? Pharm-Olam can help...

Horizon 2020 promises to create more breakthroughs, discoveries, and world-firsts. Let Pharm-Olam help you be a part of it! Learn more in our graphic.

Take A Look >

Pharm-Olam At-a-Glance

Pharm-Olam boasts over 20 years of experience in 15 therapeutic areas across 40 countries worldwide. Learn more about the leading mid-size global CRO.

Take A Look >

Ukraine Infographic

Ukraine is a viable and proven market for clinical research. View our infographic to learn more about its advantages as a potential site for your study.

Take A Look >

Turkey Infographic

Participation in clinical trials is becoming more attractive in Turkey. Find out why you should consider this region for your study in our infographic.

Take A Look >

Latin America Infographic

Latin America offers easy access to a diverse patient population, along with many other benefits. View our infographic to learn more about this region.

Take A Look >

Belarus Infographic

With its expeditious trial approval and rapid patient enrollment, Belarus could be an excellent site for your next study. Find out more in our infographic.

Take A Look >

STUDY SPOTLIGHT: Recruitment of Patients for a Phase III SLE Clinical Trial

Infectious disease is the third-largest therapeutic area of clinical research. Pharm-Olam is here to help you stand out and guide more successful studies.

Watch the Video >

Be the Big Fish: Get your Anti-Infectives Treatment to Market Faster

Watch the video to learn more about our full service Anti-Infective clinical trial capabilities.

Watch the Video >

Itching for a better Allergy & Asthma CRO?

At Pharm-Olam, we’re here to help. Our experienced global staff has extensive experience in the processing and management of allergy clinical trials.

Watch the Video >

Corporate Overview Video

As a pharmaceutical or biotechnology company, clinical trials are an exhausting hurdle. That’s why you need a reliable, experienced CRO like Pharm-Olam.

Watch the Video >

Webinar: The Evolution of Response Evaluation in Oncology Trials

In the following webinar, we discuss the history, principles, and criteria of response evaluation in oncology trials. Click below to watch our presentation.

View the Webinar >

Webinar: The Do's and Don'ts of Study Transfer

Rescue studies come in many forms. Here, we discuss our experience with over 75 rescue/supplementation studies and offer advice for smooth study transfer.

View the Webinar >

Webinar: Antibiotics Drug Development

Antibiotic drug development is ever-changing. This webinar lays out the challenges to plan for during study design and tips to maximize its effectiveness.

View the Webinar >

Webinar: Discover Latin America - A World of Clinical Research Opportunity

Latin America offers a vast pool of diverse patients for your upcoming clinical trials. This webinar provides a wealth of information on the region’s advantages.

View the Webinar >

Webinar: Current Status of Clinical Trials in India

India’s regulatory environment has made it difficult to conduct clinical trials, but policy makers are improving these conditions. Learn more in our webinar.

View the Webinar >

Thrombotic Thrombocytopenic Purpura Case Study

In this Phase III study, Pharm-Olam partnered with a progressive company to help find a better solution for those suffering with this deadly, rare disease.

Learn More >

Allergic Rhinitis

Allergic rhinitis affects between 10% and 25% of the worldwide population, and is observed most in ecologically unfavorable regions. See our study for more.

Learn More >

Glioblastoma / Anaplastic Astrocytoma Case Study

Glioblastoma / Anaplastic Astrocytoma is a brain tumor with very few available therapies. Learn more about our search for effective treatment options.

Learn More >

Recruitment of Patients in a Phase III Systemic Lupus Erythematosus Study

SLE is a notoriously difficult-to-diagnose autoimmune disorder with no known cure. Our study aimed to find a treatment for severe cases of the disorder.

Learn More >

Webinar: Successful Management of Global Studies in Emerging Markets

In this webinar, our three speakers discuss how to manage global studies in emerging markets considering the CRO and Central Laboratory perspective.

View the Webinar >

Rescue and Transfer of a Bioequivalence Breast Cancer Study

Pharm-Olam was called on to rescue a Breast Cancer bioequivalence study. Learn how this transition process successfully supported the study sponsor.

Learn More >

Accuracy and Compliance in a Phase I/II Trial Involving Preterm Neonates

Pharm-Olam provided clinical research services on a pediatric Respiratory Distress Syndrome study. Discover the unique challenges and solutions involved.

Learn More >

Webinar: Running Successful Trials in Emerging Regions

This webinar reviews tips on how technology can maximize success when running trials in emerging regions, as evidenced by Pharm-Olam’s partnership with ERT.

View the Webinar >

Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Pharm-Olam provided a complete enrollment solution for this ABSSSI study. Learn how Pharm-Olam’s efficiency allowed for a quick turnaround in this study.

Learn More >

Webinar: History, Process and Tips to Run Successful Clinical Trials in Ukraine and Neighboring Countries

Trial managers are expanding their efforts into non-traditional countries to obtain data. This webinar provides tips for successful trials in Ukraine.

View the Webinar >

Systemic Lupus Erythematosus with Lupus Nephritis (Orphan)

Learn how Pharm-Olam overcame difficult enrollment challenges in a massive Systemic Lupus Erythematosus trial and earned high praise from the sponsor.

Learn More >

Automated Sample Retention Solution for BA/BE Studies

BA/BE studies require samples of the investigational product to be retained. Learn about Pharm-Olam’s automated solution that saves time and resources.

Learn More >

Rheumatoid Arthritis

Pharm-Olam rescued a Rheumatoid Arthritis study suffering low enrollment. Learn how Pharm-Olam delivered 75% of the requirement not provided by the other CRO.

Learn More >

Webinar: Clinical Trials in Ukraine

Ukraine boasts recruitment figures two times higher than in the U.S. and Western Europe. We go over important considerations for clinical trials in this region.

View the Webinar >

Birch and Grass Pollen Allergy Studies

Learn how Pharm-Olam handled challenges such as unpredictable seasons and high patient withdrawal rates in these Birch and Grass Pollen Allergy studies.

Learn More >

Rhinitis, Seasonal

Pharm-Olam rescued this Rhinitis study by recruiting 263 children across 10 centers in Poland in two seasons, gaining praise from the Study Sponsor Manager.

Learn More >

Pediatric Asthma

Pharm-Olam rescued this study begun by another CRO struggling to meet recruitment deadlines. Learn how the successful rescue led to an NDA drug approval.

Learn More >

Glaucoma and Ocular Hypertension

Learn how Pharm-Olam provided monitoring for all 456 patients in this Glaucoma and Ocular Hypertension study, along with other crucial study support.

Learn More >

Prostate Cancer

Learn how Pharm-Olam assisted with strategy and implementation in this prostate cancer study and how it led to more research opportunities with the sponsor.

Learn More >

Breast Cancer

Pharm-Olam aided in the recruitment of 723 patients for this breast cancer study. Learn more about the challenges Pharm-Olam expertly tackled for the sponsor.

Learn More >

Head and Neck Cancer

Learn how Pharm-Olam took over and provided a smooth transition for existing sites and achieve enrollment objectives in this head and neck cancer study.

Learn More >

Post-Operative Pain

Learn how Pharm-Olam provided aggressive enrollment services in this hemorrhoidectomy study and ultimately earned the entire Phase III study from the sponsor.

Learn More >

Post Herpetic Neuralgia

Pharm-Olam’s experience level and proactive approach were critical in the speedy recruitment of patients for this Phase II Post Herpetic Neuralgia study.

Learn More >

Response Evaluation in Oncology Trials

In this eBook, we review the history of response evaluation in oncology trials as it has changed alongside technology and share our view of its future.

Learn More >

Community Acquired Pneumonia

Pharm-Olam provided global project management in this competitive recruitment study, carrying out the sponsor’s needs smoothly and efficiently.

Learn More >

Approaching a Post-Antibiotic Era: Trends in Antibiotic Research

This eBook provides an overview of the challenges we continue to face with antibiotic and bacterial resistance.

Learn More >

Predictive Resupply in Clinical Research: How to Cut Costs and Ensure Adherence to Study Protocols

This whitepaper explains the shortcomings of the floor-and-ceiling drug resupply method. We outline a 5-step algorithm for your clinical trial to cut costs and adhere to protocols.

Learn More >

Anemia in Chronic Kidney Disease Patients

Discover how Pharm-Olam handled two challenging studies in anemia with chronic kidney disease patients involving over 25 USA sites and 100 patients.

Learn More >

Reconsidering India as a Clinical Trial Location

India's regulatory environment has made it difficult to conduct clinical research. This whitepaper explores how policies have evolved in recent years.

Learn More >

Acute Myeloid Leukemia

We recommended recruitment sites in Georgia in order to meet deadlines for this study. The sponsor later selected Pharm-Olam to run a second study in the same region.

Learn More >

Clinical Trials in Canada: A Separate but Familiar Venue

The United States is a common site for launching Phase I-III clinical trials, but Canada offers similar prospects for trial success and should not be overlooked.

Learn More >

Clinical Trials in Latin America: A Region of Diversity, A World of Opportunity

Latin America, which boasts easy access to a diverse patient population, is more conducive to conducting clinical trials than ever before. Find out more in these pages.

Learn More >

Pain Treatment After Open Abdominal Hysterectomy

Learn about Pharm-Olam’s role in this abdominal pain treatment study and how we met the enrollment goal 1 week early despite unexpected challenges.

Learn More >

Clinical Trials in Ukraine: Untapped Potential & Proven Experience

Despite political unrest in a small section of the country, clinical trials are thriving in Europe’s second largest country. Read our whitepaper to learn more.

Learn More >

Ulcerative Colitis

Find out how Pharm-Olam rescued a study taking place in France and Belgium by recommending Poland as an enrollment site, meeting requirements far in advance.

Learn More >

Conducting Clinical Trials in Turkey: A Resource Guide for Sponsors

Turkey is an up-and-coming location for savvy clinical trial managers. Read on for a comprehensive guide to the country’s dynamic research environment.

Learn More >

Thromboembolism

Learn how Pharm-Olam beat enrollment goals and stayed ahead of schedule in this Phase III study for prevention of blood clots after hip replacement surgery.

Learn More >

Clinical Trials in Belarus: A Primer for Sponsors

Belarus is a hidden gem for clinical trial managers. In these pages, you will learn about its high enrollment rates, favorable cost structure, and more.

Learn More >

Acromegaly (Orphan, Phase III)

Pharm-Olam overcame a long list of challenges in this acromegaly study. Learn how we met enrollment goals and earned an extension study from the sponsor.

Learn More >

Clinical Trials in Emerging Markets: Goldmines or Landmines?

Biopharmaceutical companies are turning toward emerging markets to reduce clinical trial costs and timelines. Here, we weigh the benefits and drawbacks.

Learn More >

Acute Bacterial and Skin Structure Infections (Phase IV and Oral)

Pharm-Olam completed enrollment using only 41 out of the 49 planned sites in this study. Find out what the sponsor had to say about the efficiency of our services.

Learn More >

Clinical Trials in Russia:The Promise and the Approach

Thanks to its large population and centralized health care system, Russia has become an excellent choice for clinical trials. Our whitepaper details why.

Learn More >

Pulmonary Arterial Hypertension in Eastern Europe

Pharm-Olam played an integral part in the enrollment of the additional patients in this Phase III study. Discover how we met and surpassed those goals.

Learn More >

Passing the Baton: The Do's and Don'ts of Study Transfer

Sponsors don’t expect to transfer responsibility of a trial to a new CRO—but it can be necessary. Here, we show what a successful transfer looks like.

Learn More >

Glabellar Lines (Phase II)

Learn how Pharm-Olam approached short recruitment timelines in this Phase II dermatology study and managed to meet deadlines 5 weeks ahead of schedule.

Learn More >

Acromegaly (Orphan, Phase I/II)

Pharm-Olam was contracted to perform and manage all aspects of this Phase I/II Acromegaly study. The sponsor later awarded us their Phase III study.

Learn More >

Crohn's Disease

Learn how Pharm-Olam resolved challenges and met tough deadlines in this Phase III Crohn’s disease study, which ultimately led to a successful FDA application.

Learn More >

Ventilator-Associated Pneumonia Case Study

VAP demands that meticulous care efforts be taken. Pharm-Olam proudly partnered with a progressive drug development company in their search for a solution.

Learn More >